Here are featured articles for you to view. You can click the date and title to read the full press release.
Israel's BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration has designated its adult stem cell treatment as a "fast-track" product for the treatment of amyotrophic lateral sclerosis (ALS).
Newswise Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.
Millions of Americans took the challenge. They doused themselves with ice water and sent a check to the ALS Association to help fund the fight against the almost always deadly disease. Now, there is hope for a treatment, coming out of Isreal.
Why? Apart from their unique ability to morph and change into other stem cells, thus treating a far wider range of illnesses and conditions, mesenchymal stem cells can proliferate outside the body, and where children are concerned no tooth extraction is needed as they fall out naturally. Above all it is important to remember that the best type of cells are those which are young, and therefore have not been contaminated by a lifetime of use and exposure.
Ryan Benton, a 28 year-old Duchenne’s muscular dystrophy patient from Wichita, Kansas, received his first umbilical cord tissue-derived mesenchymal stem cell treatment yesterday at Asthma and Allergy Specialists of Wichita, KS following US FDA approval of his doctor’s application for a single patient, investigational new drug (IND) for compassionate use.
‘So far appears safe, without side effects’
Hong Kong LEmed, the specialist stem cell and laser therapy research and distribution group, announced today that it is supporting ALS research which uses Adult Stem Cells, the only stems cells to successfully complete clinical trials for incurable diseases.
In this Good Morning Texas segment, Dr. Bill Johnson explains how SVF Stem Cell Therapy can be used for Neuropathy, MS, ALS, knee replacement, and shoulder replacement. A full transcript of the conversation is listed below.
Donating to Research through...Research!
MELBOURNE, Australia, June 18, 2014 – Results from the Phase 2 trial of Mesoblast’s proprietary adult stem cells in type 2 diabetes patients have been presented at the scientific sessions of the American Diabetes Association annual meeting.